8-KThe WireRoutine
Company Update
Filed Jun 6, 2024 · 2y ago · Accession 0001140361-24-029050
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- BridgeBio Pharma, Inc.
- Ticker
- BBIO
- CIK
- 1743881
- Form type
- 8-K
- Filing date
- Jun 6, 2024
- Report date
- Jun 4, 2024
- Document
- ef20030678_8k.htm
- Size
- 195 KB